vs
康美(CNMD)与BRC Group Holdings, Inc.(RILY)财务数据对比。点击上方公司名可切换其他公司
康美的季度营收约是BRC Group Holdings, Inc.的1.7倍($317.0M vs $188.3M),BRC Group Holdings, Inc.净利率更高(47.9% vs 4.4%,领先43.6%),康美同比增速更快(-1.3% vs -21.9%),过去两年康美的营收复合增速更高(-2.3% vs -15.4%)
康美公司是一家上市的美国医疗设备制造商,主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品,总部现位于佛罗里达州拉戈,2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化,以助力医疗合作方及其服务的患者为核心使命,在美国和墨西哥都设有生产基地。
CNMD vs RILY — 直观对比
营收规模更大
CNMD
是对方的1.7倍
$188.3M
营收增速更快
CNMD
高出20.5%
-21.9%
净利率更高
RILY
高出43.6%
4.4%
两年增速更快
CNMD
近两年复合增速
-15.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $317.0M | $188.3M |
| 净利润 | $13.8M | $90.3M |
| 毛利率 | 57.9% | 79.5% |
| 营业利润率 | 8.0% | 32.3% |
| 净利率 | 4.4% | 47.9% |
| 营收同比 | -1.3% | -21.9% |
| 净利润同比 | 129.1% | 1710.8% |
| 每股收益(稀释后) | $0.45 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CNMD
RILY
| Q1 26 | $317.0M | — | ||
| Q4 25 | $373.2M | $188.3M | ||
| Q3 25 | $337.9M | $215.3M | ||
| Q2 25 | $342.3M | $188.2M | ||
| Q1 25 | $321.3M | $197.2M | ||
| Q4 24 | $345.9M | $241.0M | ||
| Q3 24 | $316.7M | $225.5M | ||
| Q2 24 | $332.1M | $256.0M |
净利润
CNMD
RILY
| Q1 26 | $13.8M | — | ||
| Q4 25 | — | $90.3M | ||
| Q3 25 | $2.9M | $91.1M | ||
| Q2 25 | $21.4M | $139.5M | ||
| Q1 25 | $6.0M | $-10.0M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | $49.0M | $-284.4M | ||
| Q2 24 | $30.0M | $-433.6M |
毛利率
CNMD
RILY
| Q1 26 | 57.9% | — | ||
| Q4 25 | 58.5% | 79.5% | ||
| Q3 25 | 49.2% | 83.7% | ||
| Q2 25 | 55.0% | 81.3% | ||
| Q1 25 | 55.3% | 81.4% | ||
| Q4 24 | 57.3% | 79.8% | ||
| Q3 24 | 56.5% | 82.1% | ||
| Q2 24 | 55.3% | 84.5% |
营业利润率
CNMD
RILY
| Q1 26 | 8.0% | — | ||
| Q4 25 | 9.8% | 32.3% | ||
| Q3 25 | 3.5% | 30.4% | ||
| Q2 25 | 11.1% | 5.7% | ||
| Q1 25 | 5.0% | -31.2% | ||
| Q4 24 | 15.2% | -69.2% | ||
| Q3 24 | 20.7% | -36.4% | ||
| Q2 24 | 14.2% | -90.8% |
净利率
CNMD
RILY
| Q1 26 | 4.4% | — | ||
| Q4 25 | — | 47.9% | ||
| Q3 25 | 0.8% | 42.3% | ||
| Q2 25 | 6.3% | 74.1% | ||
| Q1 25 | 1.9% | -5.1% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | 15.5% | -126.1% | ||
| Q2 24 | 9.0% | -169.4% |
每股收益(稀释后)
CNMD
RILY
| Q1 26 | $0.45 | — | ||
| Q4 25 | $0.54 | $2.78 | ||
| Q3 25 | $0.09 | $2.91 | ||
| Q2 25 | $0.69 | $4.50 | ||
| Q1 25 | $0.19 | $-0.39 | ||
| Q4 24 | $1.09 | $-0.01 | ||
| Q3 24 | $1.57 | $-9.39 | ||
| Q2 24 | $0.96 | $-14.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | — | $-171.5M |
| 总资产 | — | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CNMD
RILY
| Q1 26 | — | — | ||
| Q4 25 | — | $226.6M | ||
| Q3 25 | — | $184.2M | ||
| Q2 25 | — | $267.4M | ||
| Q1 25 | — | $138.3M | ||
| Q4 24 | — | $146.9M | ||
| Q3 24 | — | $159.2M | ||
| Q2 24 | — | $236.9M |
总债务
CNMD
RILY
| Q1 26 | — | — | ||
| Q4 25 | $834.2M | $1.4B | ||
| Q3 25 | $853.0M | $1.3B | ||
| Q2 25 | $881.1M | $1.3B | ||
| Q1 25 | $891.4M | $1.4B | ||
| Q4 24 | $905.1M | $1.5B | ||
| Q3 24 | $940.1M | — | ||
| Q2 24 | $965.2M | — |
股东权益
CNMD
RILY
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $-171.5M | ||
| Q3 25 | $1.0B | $-260.5M | ||
| Q2 25 | $1.0B | $-351.7M | ||
| Q1 25 | $977.6M | $-496.8M | ||
| Q4 24 | $962.7M | $-488.2M | ||
| Q3 24 | $932.9M | $-497.6M | ||
| Q2 24 | $881.8M | $-218.3M |
总资产
CNMD
RILY
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | $1.7B | ||
| Q3 25 | $2.3B | $1.7B | ||
| Q2 25 | $2.3B | $1.5B | ||
| Q1 25 | $2.3B | $1.5B | ||
| Q4 24 | $2.3B | $1.8B | ||
| Q3 24 | $2.3B | $2.2B | ||
| Q2 24 | $2.3B | $3.2B |
负债/权益比
CNMD
RILY
| Q1 26 | — | — | ||
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.09× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $26.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.29× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CNMD
RILY
| Q1 26 | — | — | ||
| Q4 25 | $46.3M | $26.2M | ||
| Q3 25 | $53.7M | $-60.6M | ||
| Q2 25 | $29.1M | $-25.6M | ||
| Q1 25 | $41.5M | $184.0K | ||
| Q4 24 | $43.3M | $-2.7M | ||
| Q3 24 | $51.2M | $19.5M | ||
| Q2 24 | $43.3M | $111.5M |
自由现金流
CNMD
RILY
| Q1 26 | — | — | ||
| Q4 25 | $41.2M | — | ||
| Q3 25 | $48.5M | — | ||
| Q2 25 | $23.4M | — | ||
| Q1 25 | $37.8M | — | ||
| Q4 24 | $39.3M | — | ||
| Q3 24 | $47.8M | — | ||
| Q2 24 | $39.7M | — |
自由现金流率
CNMD
RILY
| Q1 26 | — | — | ||
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.4% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 11.8% | — | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 12.0% | — |
资本支出强度
CNMD
RILY
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 1.1% | — |
现金转化率
CNMD
RILY
| Q1 26 | — | — | ||
| Q4 25 | — | 0.29× | ||
| Q3 25 | 18.78× | -0.66× | ||
| Q2 25 | 1.36× | -0.18× | ||
| Q1 25 | 6.88× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.44× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNMD
暂无分部数据
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |